AAA - Abdominal Aortic Aneurysm
15
6
7
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 15 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (15)
Data Collection of the TUVA BX and iCover Stent Grafts Implanted During Branched Endovascular Aortic Repair (BEVAR)
Endurant CHevAr New Indication Trial: ENCHANT
Nectero EAST System Retreatment Study
Perioperative Hypotension and Survival After Elective AAA Repair
Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis
Targeted Abdominal CT in Conjunction With Lung Cancer Screening
JAGUAR Trial (Outside United States; OUS): ObJective Analysis to GaUge EVAR Outcomes Through Randomization
JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization
Retrospective Post-Market Clinical Follow-Up Study of GORE-TEX® Vascular Grafts and GORE® PROPATEN® Vascular Graft in Peripheral Artery Disease, Aortic Aneurysms, and Dialysis Access
Virtual Prehabilitation for Patients Undergoing Abdominal Aortic Aneurysm Repair
Prediction of Abdominal Aortic Aneurysm Shrinkage After Stent-placement With Artificial Intelligence
Automatic Abdominal Aortic Aneurysm Diameter Measurement
Sex-specific Differences in AAA Complexity
A Study of the Safety of Targeted AAA Screening
Cross-sectional Study of Prevalence Rate of Abdominal Aortic Aneurysm in OSAHS Patients From BTCH